Showing results (371-380 of 1,811) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|May 12, 2026
Fludarabine-Treosulfan (FT10) Conditioning in Older AML Patients Undergoing Haploidentical Transplantation: A Prospective Italian Study with External Comparison to the Haplo-UK Reduced-Intensity Conditioning CohortVincenzo Federico, Daniele Avenoso, Kavita Raj, et al.
Transplantation and Cellular Therapy|May 10, 2026
Secondary Malignancies after Hematopoietic Stem Cell TransplantationPedro Asensi Cantó, Miguel Mansilla-Polo, Juan Montoro, et al.
Transplantation and Cellular Therapy|May 22, 2026
Outcomes of Hematopoietic Cell Transplantation in Patients with Plasmablastic LymphomaTaha Al-Juhaishi, Kwang Woo Ahn, Tiening Chen, et al.
Transplantation and Cellular Therapy|May 22, 2026
Low SOS/VOD Risk with Inotuzumab Ozogamicin as a Bridging Strategy to Second Allogeneic HSCT: A Real-World Study in Post-Transplant Relapsed B-ALLFei Pan, Jing Long, Man Chen, et al.
Transplantation and Cellular Therapy|May 13, 2026
Long-Term Gynecologic and Reproductive Health in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis of PrevalenceMuhammad Kashif Amin, Nabeeha Noor, Muhammad Talha Maqsood, et al.
Transplantation and Cellular Therapy|May 17, 2026
Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector CellsViktoria Blumenberg, Caroline Diorio, Jordan Gauthier, et al.
Transplantation and Cellular Therapy|May 17, 2026
Impact of Renal Impairment and Lymphodepletion Regimen on Outcomes after CAR T Cell Therapy in Relapsed/Refractory Multiple MyelomaNora Grieb, Thomas Wiemers, Patrick Born, et al.
Transplantation and Cellular Therapy|February 20, 2026
Musculoskeletal Adverse Events Following BCMA CAR-T Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune CorrelatesAmber Feng, Jian Wu, Taewoong Choi, et al.
Transplantation and Cellular Therapy|June 8, 2026
Lung Complications after Allogeneic Hematopoietic Cell Transplant and Outcomes: Implications Beyond Bronchiolitis Obliterans SyndromeYu Kuang Lai, Husham Sharifi, Sally Arai, et al.
Transplantation and Cellular Therapy|June 10, 2026
Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapiesAgrima Mian, Rafaella Litvin, Danai Dima, et al.
Pageof 182